KRAS and colorectal cancer: Mutations of the EGFR tyrosine kinase (TK) domains lead to constitutive kinase activation and were shown to be a good predictive marker in non-small cell lung cancer, while KRAS and BRAF were negative prognostic markers in colorectal cancer (12,13).